JAZMIN YACAMAN STRUBLE: Open Payments
NPI 1235808445 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 10 payments from 8 companies in 2025. Trend: 2023 $155 · 2024 $128 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $60 |
| Novo Nordisk Inc | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Tandem Diabetes Care, Inc. | 2 | $26 |
| Sequel Med Tech, LLC | 1 | $23 |
| Ascensia Diabetes Care Us Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $18 |
| Ascendis Pharma Endocrinology Inc | 1 | $15 |
Products named: Korlym, REZDIFFRA, t:slim X2 Insulin Pump with Control-IQ, TWIIST, Ozempic, MINIMED 780G, Rybelsus, Yorvipath.
Industry payments across NE — which companies pay providers there.
